IP vs TSHA · P/E 43, $26.62B cap vs rev $8.3M
International Paper (IP) versus Taysha Gene Therapies Inc (TSHA) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported TSHA revenue for 2024-12-31 was $8.3M. Net income was -$89.3M. Revenue was down 46.1% from 2023-12-31 to 2024-12-31. TSHA currently screens at market cap $640.7M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. TSHA currently screens at market cap $640.7M.
Not investment advice. Open the IP and TSHA stock pages for the full models.
Not investment advice.